1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 703 F.Supp.3d
  5. 703 F.Supp.3d 1 (2023)
 

NORWICH PHARMACEUTICALS, INC. v. BECERRA

Civil Action No. 23-1611 (RDM).

703 F.Supp.3d 1 (2023)

NORWICH PHARMACEUTICALS, INC., Plaintiff, v. Xavier BECERRA, Secretary of Health and Human Services, et al., Defendants.

United States District Court, District of Columbia.

Signed November 1, 2023.

Attorney(s) appearing for the Case

Aaron Savit, Pro Hac Vice, Matthew S. Murphy, Pro Hac Vice, Chad A. Landmon, Axinn, Veltrop & Harkrider LLP, Hartford, CT, Gabriella McIntyre, Axinn Veltrop & Harkrider, LLP, Washington, DC, Ross Ericson Blau, Pro Hac Vice, Axinn Veltrop & Harkrider, LLP, New York, NY, for Plaintiff.

Gabriel Schonfeld, U.S. Department of Justice, Washington, DC, for Defendants.

MEMORANDUM OPINION

Battles over the entry of generic drugs to market are often hard fought, particularly in cases involving brand-named drugs with annual sales that substantially exceed $1 billion. See Dkt. 1 at 11 (Compl. ¶ 41). This is a case in point...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases